Skip to main contentAI and Advanced
/
VIJAYA · NSEBSE SENSEX74,314.59-0.03%BSE |
NIFTY 5023,270.6+0.23%NSE |
NIFTY BANK56,055.75-0.42%NSE |
NIFTY IT29,155.6+0.23%NSE |
NIFTY AUTO27,159.15+0.99%NSE |
NIFTY FMCG45,572.7+0.03%NSE |
NIFTY PHARMA26,579.25+1.66%NSE |
NIFTY 50022,654.65+0.54%NSE |
VI
NSE · Equity shares · Healthcare Facilities67.80 · 4.71%
Vijaya Diagnostic Centre VIJAYA
NSE:INR 1,506.1
BSE:INR 1,509.9
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for VIJAYA
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 1,438.3
Day rangeINR 1,423.3 — INR 1,514.9
52-week rangeINR 847.9 — INR 1,578
Volume1.96 L
Market cap14,042.32
P/E51.21
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)814.2
Net Income (INR Cr)172.98
Rev Growth (5 Year %)16.66
EPS Growth (5 Year %)15.18
P/E Ratio51.21
Book Value79.37
EPS16.79
Price/BV18.98Computed
Research path: Interpret Vijaya Diagnostic Centre's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
VIJAYAVijaya Diagnostic Centre1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,507.05 | 1,273.62 | 982.75 |
| Cash Equivalents | 39.68 | 5.89 | 12.05 |
| Other Liabilities Total | 11.49 | 10.17 | 10.92 |
| Common Stock Total | 10.29 | 10.26 | 10.23 |
| Other Current Assets Total | 7.02 | 0.28 | 0.81 |
| Total Assets | 1,507.05 | 1,273.62 | 982.75 |
| Current Portof LT Debt/Capital Leases | 22.56 | 23.16 | 20.13 |
| Total Equity | 957.15 | 795.71 | 657.19 |
| Long Term Investments | 48.13 | 0.23 | 0.43 |
| Retained Earnings(Accumulated Deficit) | 946.86 | 731.29 | 596.87 |
| Total Common Shares Outstanding | 10.29 | 10.26 | 10.23 |
| Tangible Book Valueper Share Common Eq | 79.37 | 63.78 | 50.5 |
| Goodwill Net | 119.2 | 119.2 | 119.2 |
| Total Liabilities | 549.9 | 477.9 | 325.56 |
| Total Debt | 422.59 | 319.58 | 259.18 |
| Short Term Investments | 249.45 | 268.19 | 161.16 |
| Cashand Short Term Investments | 289.13 | 280.99 | 183.4 |
| Total Receivables Net | 20.86 | 14.96 | 17.64 |
| Deferred Income Tax | 14.52 | 5.28 | Not available |
| Accounts Receivable-Trade Net | 20.86 | 14.76 | 17.35 |
| Property/Plant/Equipment Total-Net | 963.92 | 793.97 | 610.38 |
| Total Current Liabilities | 123.86 | 162.61 | 72.87 |
| Total Inventory | 4.89 | 7.41 | 6.04 |
| Accounts Payable | 37.56 | 33.13 | 32.95 |
| Other Currentliabilities Total | 63.74 | 96.99 | 11.45 |
| Total Long Term Debt | 400.03 | 296.41 | 239.05 |
| Intangibles Net | 21.23 | 21.89 | 21.18 |
| Other Long Term Assets Total | 32.43 | 22.22 | 16.33 |
| Note Receivable-Long Term | 0.25 | 8.89 | 3.9 |
| Total Current Assets | 321.9 | 307.21 | 211.33 |
| Capital Lease Obligations | 400.03 | 296.41 | 239.05 |
| Accumulated Depreciation Total | Not available | -387.5 | -320.6 |
| Accrued Expenses | Not available | 9.33 | 8.34 |
| Prepaid Expenses | Not available | 3.57 | 3.43 |
| Additional Paid-In Capital | Not available | 54.16 | 50.08 |
| Cash | Not available | 6.91 | 10.19 |
| Property/Plant/Equipment Total-Gross | Not available | 1,111.21 | 922.77 |
| Notes Payable/Short Term Debt | Not available | 0 | 0 |
| Minority Interest | Not available | 3.43 | 2.72 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio3.1
Price to Sale Ratio17.25
Growth
Debt 5Yr CAGR %24.54
Margins
Operating Margin 12m30.1
Operating Margin 5y Avg29.68
Net Profit Margin 12m21.24
Net Profit Margin 5y21.32
Yield
Dividend Yield %0.14
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk37.83
Analyst consensus
ConsensusBuy
Consensus score2.13
Analyst opinions8
Strong Sell count0
Sell count1
Hold count2
Buy count2
Strong Buy count3
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 64.93 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 71.47 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.89 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 52.51%
- FII
- 11.65%
- MF
- 30.66%
- Other
- 5.18%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Raja Venkatraman, MarketSmith recommend five stocks for 3 JuneMarket news · 3 Jun 2026, 7:44 am
On June 3, Indian equity benchmarks rebounded after four days of losses, driven by IT stocks and value buying. The Nifty 50 rose 0.43% to 23,483.55. Recommendations include Vijaya Diagnostic Centre, Syrma SGS Technology, and Shyam Metalics due to strong performance and market conditions.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 17 November 2025Market news · 17 Nov 2025, 6:39 am
Sumeet Bagadia recommends five breakout stocks to buy today - HBL Engineering, Star Health and Allied Insurnc Cmpny, Doms Industries, Radico Khaitan, and Vijaya Diagnostic Centre.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 4 November 2025Market news · 4 Nov 2025, 6:37 am
Sumeet Bagadia recommends five breakout stocks to buy today: PDS, Zota Health Care, Remsons Industries, Acutaas Chemicals, and Vijaya Diagnostic Centre.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 29 July 2025Market news · 29 Jul 2025, 7:09 am
Sumeet Bagadia recommends five breakout stocks to buy today: Jagsonpal Pharmaceuticals, Sterlite Technologies, Cartrade Tech, Vijaya Diagnostic Centre, and Advait Energy Transitions.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 25 July 2025Market news · 25 Jul 2025, 6:19 am
Sumeet Bagadia recommends five breakout stocks to buy today: Vijaya Diagnostic Centre, Krishana Phoschem, Globus Spirits, Rainbow Children's Medicare, and IPCA Laboratories.
Stocks to buy for short term: MRPL to Havells— Jigar Patel of Anand Rathi recommends 3 stock picks; do you own any?Market news · 6 Jul 2025, 3:54 pm
Stocks to buy for the short term: The Nifty 50 has remained rangebound, closing at 25,461 with a slight gain. Jigar Patel suggests buying MRPL, Havells, and Vijaya Diagnostic Centre for short-term gains.
Corporate actions
Events
- annual General MeetingPOM
- board MeetingsQuarterly Results
- annual General MeetingPOM
- dividendRs.2.0000 per share(200%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
Rusaka Markets Community
Discussion and sentiment for Vijaya Diagnostic Centre
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Vijaya Diagnostic Centre Limited is an India-based company, which is engaged in the business of providing a range of diagnostic services, spanning pathological investigations, basic and high-end radiology, nuclear medicine, and related healthcare services. It operates through the Diagnostic Services segment. It offers laboratory services and radiology services. Its services include clinical pathology, microbiology, hematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, computerized tomography (CT) scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine, and MRI-3T. It operates approximately 160 diagnostic centers in 25 cities spread across India. Its clinical pathology includes liver function test (LFT-A), creatine kinase (CPK) test, and thyroid profile test. It offers various health checkups, which include general wellness, women's care, gynecology packages, and lifestyle.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- VIJAYA
- BSE Code
- 543350
Questions
Stock FAQ
What is the symbol and ISIN of Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre has the symbol VIJAYA and ISIN - INE043W01024.
What is the current price of Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre is currently trading at INR 1,506.10.
What are the year high and year low of Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre has a year high of INR 1,578.00 and a year low of INR 847.90.
What is the market capitalization of Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre has a market capitalization of INR 14,042.32 crore.
What is the P/E ratio of Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre has a P/E ratio of 51.21.
What is the dividend yield of Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre has a dividend yield of 0.14%.
How is the financial performance of Vijaya Diagnostic Centre based on revenue, net income, and EPS?
Vijaya Diagnostic Centre has revenue of INR 814.20 crore, net income of INR 172.98 crore, and EPS of INR 16.79.
What is the book value of Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre has a book value of INR 79.37.
What is the debt-to-equity ratio of Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre has a price-to-book ratio of 18.98 and a price-to-sales ratio of 17.25.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.